Well Ahead of Schedule, Decision Diagnostic's Pharma Tech Division Completes First Major Shipments of its Popular Genstrip Te...
01 November 2013 - 12:15AM
Access Wire
- genStrip sales powered by changes in medicare and
private insurance reimbursements moving demand away from mail
order pharmacy models.
- company to focus on neighborhood pharmacies who
can now ensure profit by servicing medicare patients who have lost
mail order pharmacy service.
- chain
pharmacy and other large retailers looking to buy genstrip for
retail sales and to add genstrip to service the medicare
walk-in
patients.
Los Angeles, CA, - (Accesswire - October 31, 2013 ) -
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide
sales, service and regulatory processes agent for the popular
Shasta GenStrip(TM), the unique Green Glucose Test Strip,
specifically designed to work with the Johnson & Johnson's
(NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today
announced that beginning Friday October 25 and continuing every
business day since, its Pharma Tech Solutions subsidiary has
completed the first GenStrip bulk shipments to large box
distributors of GenStrip, ahead of schedule, and in quantities
greater than expected. More shipments are planned as soon as
additional volume is available.
Keith Berman, Principal Executive Officer of Decision
Diagnostics, commented, "Beginning in July 2013, Medicare changed
its reimbursement practice with a goal of lowering the cost of
healthcare. These changes have had the impact of moving the
market away from mail order pharmacy fulfillment models, which have
dominated the last decade, and back toward traditional brick and
mortar pharmacies. The GenStrip business model works very well in
the post July 2013environment and has provided us with an
unexpected boom for our business."
DECN is a leading provider of prescription and non-prescription
diagnostics, home testing products for the chronically ill and a
premier developer of revolutionary cell phone centric e-health
products and technologies. DECN's FDA cleared Shasta GenStrip(TM)
product was first introduced to the market in late 2012 as a lower
cost (50%) glucose test strip alternative for user/owners of
Johnson and Johnson LifeScan OneTouch® Ultra®, Ultra2(R) and Ultra
Mini(R) glucose meters.
Mr. Berman concluded, "we also note that in August and September
2013 we received several favorable court rulings and our
competition ended their practice of sending threatening letters to
our customers. Earlier this week we announced the receipt of
a $12.5 million non-dilutive credit line, adding to the positive
outlook for Genstrip sales by allowing us to grow to $250+ million
in sales."
The company also reminds shareholders and all interested parties
that it continues to air its new commercial video titled "GenStrip:
A Patchwork of Life." The company’s video will begin play today. As
soon as the media company produces the complete media schedule, we
will post this schedule on our Web Sites. In the meantime the
extremely popular video is available for viewing at:
http://shastagenstrip.com/shasta_ad.html or
http://youtu.be/zzBuHxb-rlM
Forward-Looking Statements:
This release contains forward-looking statements about our business
or financial condition that reflect our assumptions and beliefs
based on information currently available. We can give no assurance
that the expectations indicated by such forward-looking statements
will be realized. There may be other risks and circumstances that
we are unable to predict. When used in this release, words such as
"believes," "expects," "forecasts," "intends," "projects," "plans,"
"anticipates," "estimates," "will" and similar expressions are
intended to identify forward-looking statements, although there may
be certain statements not accompanied by such expressions.
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com or
http://www.shastagenstrip.com.
GenStrip(TM) test strips are a product of Shasta Technologies,
LLC and are not manufactured, distributed, endorsed, or approved by
nor associated with LifeScan(R), Inc. a Johnson & Johnson(R)
Company, manufacturers and distributors of the OneTouch(R) Ultra(R)
Family of Meters and OneTouch(R) Ultra(R) test strips.
Contact:
Decision Diagnostics Corp.
Keith Berman
(805) 446-2973
info@decisiondiagnostics.com
Decision Diagnostics (CE) (USOTC:DECN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Decision Diagnostics (CE) (USOTC:DECN)
Historical Stock Chart
From Jul 2023 to Jul 2024